You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies
|
---|---|
Published in |
Orphanet Journal of Rare Diseases, May 2020
|
DOI | 10.1186/s13023-020-01379-8 |
Pubmed ID | |
Authors |
Thomas Opladen, Eduardo López-Laso, Elisenda Cortès-Saladelafont, Toni S. Pearson, H. Serap Sivri, Yilmaz Yildiz, Birgit Assmann, Manju A. Kurian, Vincenzo Leuzzi, Simon Heales, Simon Pope, Francesco Porta, Angeles García-Cazorla, Tomáš Honzík, Roser Pons, Luc Regal, Helly Goez, Rafael Artuch, Georg F. Hoffmann, Gabriella Horvath, Beat Thöny, Sabine Scholl-Bürgi, Alberto Burlina, Marcel M. Verbeek, Mario Mastrangelo, Jennifer Friedman, Tessa Wassenberg, Kathrin Jeltsch, Jan Kulhánek, Oya Kuseyri Hübschmann |
X Demographics
The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 11 | 28% |
United States | 3 | 8% |
United Kingdom | 2 | 5% |
Netherlands | 1 | 3% |
India | 1 | 3% |
Venezuela, Bolivarian Republic of | 1 | 3% |
Portugal | 1 | 3% |
Italy | 1 | 3% |
Unknown | 18 | 46% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 31 | 79% |
Scientists | 4 | 10% |
Practitioners (doctors, other healthcare professionals) | 2 | 5% |
Science communicators (journalists, bloggers, editors) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 151 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 151 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 20 | 13% |
Student > Ph. D. Student | 19 | 13% |
Student > Bachelor | 16 | 11% |
Student > Master | 10 | 7% |
Student > Doctoral Student | 8 | 5% |
Other | 22 | 15% |
Unknown | 56 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 17% |
Biochemistry, Genetics and Molecular Biology | 19 | 13% |
Neuroscience | 13 | 9% |
Agricultural and Biological Sciences | 7 | 5% |
Nursing and Health Professions | 6 | 4% |
Other | 21 | 14% |
Unknown | 60 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2024.
All research outputs
#1,194,781
of 25,732,188 outputs
Outputs from Orphanet Journal of Rare Diseases
#126
of 3,179 outputs
Outputs of similar age
#34,976
of 430,573 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#2
of 56 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,179 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,573 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.